Toward a specific classification of polypoidal choroidal vasculopathy: Idiopathic disease or subtype of age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 5, 2015, Pages 3187-3195

  Coscas, Gabriel ^a,b   Lupidi, Marco ^b,c   Coscas, Florence ^a,b   Benjelloun, Fayçal ^a   Zerbib, Jennifer ^a   Dirani, Ali ^d   Semoun, Oudy ^a   Souied, Eric H ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b Centre de l’Odéon ^*  (France)

^c UNIVERSITY OF PERUGIA   (Italy)

^d SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Age related macular degeneration (AMD); Choroidal abnormal network; Choroidal thickness; En face optical coherence tomography (OCT); Enhanced depth imaging (EDI); Polypoidal choroidal vasculopathy; Type 1 choroidalneovascularization (CNV)

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; BLEEDING; BRANCHING VASCULAR NETWORK; CHOROIDAL ABNORMAL NETWORK; DRUSEN; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IDIOPATHIC DISEASE; INDOCYANINE GREEN ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; POLYP; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA PIGMENT EPITHELIOPATHY; RETROSPECTIVE STUDY; SCANNING LASER OPHTHALMOSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; CHOROID; CHOROIDAL NEOVASCULARIZATION; CLASSIFICATION; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MULTIMODAL IMAGING; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; POLYPS; VERY ELDERLY; WET MACULAR DEGENERATION;

COLORING AGENT; INDOCYANINE GREEN;

AGED; AGED, 80 AND OVER; CHOROID; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OPHTHALMOSCOPY; POLYPS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84939641203     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-16236     Document Type: Article

References (39)

1. Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nihon Ganka Gakkai Zasshi. 2005;109:417–427.
2. Imamura Y, Engelbert M, Iida T, Freund KB, Yannuzzi LA. Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol. 2010;55:501–515.
3. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011;118:840–845.
4. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal vasculopathy (IPCV). Retina. 1990;10:1–8.
5. Kleiner RC, Brucker AJ, Johnston RL. Posterior uveal bleeding syndrome. Ophthalmology. 1984;91(suppl 9):110.
6. Stern RM, Zakov ZN, Zegarra H, Gutman FA. Multiple recurrent serosanguineous retinal pigment epithelial detachment in black women. Am J Ophthalmol. 1985;100:560–569.
7. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina. 1995;15:100–110.
8. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA. The expanding clinical spectrum of Idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol. 1997; 115:478–485.
9. Yannuzzi LA, Nogueira FB, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol. 1998;116:382–383.
10. Yannuzzi LA, Wong DWK, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Arch Ophthalmol. 1999;117:1503–1510.
11. Laude A, Cackett PD, Vithana EN. at al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2010;29: 19–29.
12. Koh AH, Chen LJ, Chen SJ, et al.; Expert PCV Panel. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina. 2013;33:686–716.
13. Lafaut BA, Leys AM, Snyers B, Rasquin F, De Laey JJ. Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol. 2000;238:752–759.
14. Ladas ID, Rouvas AA, Moschos MM, Synodinos EE, Karagiannis DA, Koutsandrea CN. Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye. 2004;18:455–459.
15. Scassellati-Sforozolini B, Mariotti C, Bryan R, Yannuzzi LA, Giuliani M, Giovannini A. Polypoidal choroidal vasculopathy in Italy. Retina. 2001;21:121–125.
16. Davis SJ, Lauer AK, Flaxel CJ. Polypoidal choroidal vasculopathy in white patients. Retina. 2014;34:2185–2191.
17. Coscas G, Yamashiro K, Coscas F, et al. Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol. 2014;158:309–318.
18. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15–22.
19. De Salvo G, Vaz-Pereira S, Keane PA, Tufail A, Liew G. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol. 2014;158:1228–1238.
20. Tan CS, Ngo WK, Lim LW, Lim TH. A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol. 2014;98:1528–1533.
21. Cheung CM, Lai TY, Chen SJ, et al. Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy. Retina. 2014;34: 2397–2406.
22. Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2005;89:602–607.
23. Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectraldomain optical coherence tomography. Retina. 2009;29:52–59.
24. Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina. 2007;27:589–594.
25. Tsujikawa A, Sasahara M, Otani A, et al. Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am JOphthalmol. 2007;143:102–111.
26. Kawamura A, Yuzawa M, Mori R, Haruyama M, Tanaka K.Indocyanine green angiographic and optical coherencetomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol. 2013;91:e474–e481.
27. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol. 2009;147:801–810.
28. Coscas F, Coscas G, Srour M, et al. Comparison of macular choroidal thickness in adult onset foveomacular vitelliformdystrophy and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:64–69.
29. Nakashizuka H, Mitsumata M, Okisaka S, et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49:4729–4737.
30. Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels ofvascular endothelial growth factor and pigment epitheliumderived factor in polypoidal choroidal vasculopathy andchoroidal neovascularization. Am J Ophthalmol. 2006;141: 456–462.
31. Chen H, Liu K, Chen LJ, et al. Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Mol Vis. 2012;18:816–829.
32. Tanaka K, Nakayama T, Mori R, et al. Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2011;52:7441–7444.
33. Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2010;29: 19–29.
34. Yanagisawa S, Kondo N, Miki A, et al. Difference between agerelated macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2). Mol Vis. 2011;17:3574–3582.
35. Sakurada Y, Kubota T, Mabuchi F, Imasawa M, Tanabe N, Iijima H. Association of LOC387715 A69S with vitreous hemorrhagein polypoidal choroidal vasculopathy. Am J Ophthalmol. 2008; 145:1058–1062.
36. Park DH, Kim IT. Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population. Jpn J Ophthalmol. 2012;56:60–67.
37. Honda S, Matsumiya W, Negi A. Polypoidal choroidal vasculopathy: clinical features and genetic predisposition. Ophthalmologica. 2014;231:59–74.
38. Koh A, Lee WK, Chen LJ, et al. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina. 2012;32:1453–1464.
39. Wang W, He M, Zhang X, et al. Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies. PLoS One. 2014;24;9:e110667.